get a key
steadybase-$ company NGVT
account_id none on file
legal_name Ingevity Corp
ticker NGVT
cik 1653477
domain ingevity.com
entry_point_account_id none on file
name Ingevity Corporation
exchange NYSE
sector Industrials
calls 2 filings 67 executives 7 family 0
why_nownone on file
calls
This week marks my fourth month with Ingevity. As I've traveled to our sites and met with our teams globally, I've been energized by the passion and pride our people bring to work every day. The Ingev-Away, our shared values and mission to purify, protect, and enhance the world around us, is deeply embedded across the company. And what I consistently hear from our organization is that they feel we have reached an inflection point and are ready to start winning again.

Aug 5, 2025 / receipt, needs a key / David Lee, CEO | earnings call 2025-08-05 | transcript 46306c53-411e-4c03-84c4-04fe8c6b39fc | chars 1796-2267 | segment 1

Ed Woodcock, President of Performance Materials, is traveling.

Feb 19, 2025 / receipt, needs a key / Ed Woodcock, other | earnings call 2025-02-19 | transcript ff74887d-ba84-449f-90dc-e56623a2379f | chars 1670-1732 | segment 1

filings
Restructuring charges $ 1.7 $ 7.2 $ 2.2 $ 9.1 Other (income) charges, net - - - - Total Restructuring and other (income) charges, net $ 1.7 $ 7.2 $ 2.2 $ 9.1 20 INGEVITY CORPORATION Notes to the Condensed Consolidated Financial Statements June 30, 2026 (Unaudited) Restructuring Charges In millions Severance and other employee-related costs Other charges (income) (1) Asset disposal charges Total

filing / Jul 30, 2026 / receipt

Restructuring Charges In millions Severance and other employee-related costs Other charges (income) (1) Asset disposal charges Total Performance Chemicals repositioning (2) $ - $ 0.4 $ - $ 0.4 Other 0.8 0.5 - 1.3 Three Months Ended June 30, 2026 $ 0.8 $ 0.9 $ - $ 1.7 Performance Chemicals repositioning (2) $ - $ 0.7 $ - $ 0.7 Other 1.7 0.5 4.3 6.5 Three Months Ended June 30, 2025 $ 1.7 $ 1.2 $ 4.3

filing / Jul 30, 2026 / receipt

Overall, SG&A decreased by $4.6 million (11 percent), driven by decreased intangible amortization expense of $3.3 million, decreased spending on commercial activities of $1.2 million, and decreased variable incentive compensation of $0.1 million.

filing / Jul 30, 2026 / receipt

Overall, SG&A decreased by $5.8 million (seven percent), driven by decreased intangible amortization expense of $5.6 million, and decreased spending on commercial activities of $1.6 million.

filing / Jul 30, 2026 / receipt

Restructuring charges $ 0.5 $ 1.9 Other (income) charges, net - - Total Restructuring and other (income) charges, net $ 0.5 $ 1.9 Restructuring Charges In millions Severance and other employee-related costs Other charges (income) (1) Asset disposal charges Total Performance Chemicals repositioning (2) $ - $ 0.4 $ 0.4 $ 0.8 Other ( 0.3 ) - - ( 0.3 ) Three Months Ended March 31, 2026 $ ( 0.3 ) $ 0.4 $

filing / May 7, 2026 / receipt

Restructuring Charges In millions Severance and other employee-related costs Other charges (income) (1) Asset disposal charges Total Performance Chemicals repositioning (2) $ - $ 0.4 $ 0.4 $ 0.8 Other ( 0.3 ) - - ( 0.3 ) Three Months Ended March 31, 2026 $ ( 0.3 ) $ 0.4 $ 0.4 $ 0.5 Performance Chemicals repositioning $ - $ 0.7 $ - $ 0.7 Other 0.8 0.3 0.1 1.2 Three Months Ended March 31, 2025 $ 0.8 $

filing / May 7, 2026 / receipt

Overall, SG&A decreased by $1.2 million (three percent), driven by decreased intangible amortization expense of $2.3 million, and decreased spending on commercial activities of $0.4 million, partially offset by increased variable incentive compensation of $1.5 million.

filing / May 7, 2026 / receipt

Additional charges include $1.0 million in miscellaneous costs primarily associated with the exit of our Performance Chemicals' manufacturing operations in Palmeira, Santa Catarina, Brazil.

ir_statement / Sep 17, 2026 / receipt

Charges incurred for the three months ended March 31, 2016 include severance and other employee-related costs of $1.8 million related to the closure of our Performance Chemicals' derivatives operation

ir_statement / Sep 17, 2026 / receipt

Charges incurred for the three months ended March 31, 2017 include $1.3 million in severance and other employee-related costs related to a reorganization as part of an effort to streamline our leaders

ir_statement / Sep 17, 2026 / receipt

Strong productivity benefits driven by 2016 cost reduction initiatives and lower raw material costs

ir_statement / Sep 17, 2026 / receipt

Significant benefit from cost reduction initiatives and lower raw material costs, especially CTO

ir_statement / Sep 17, 2026 / receipt

executives
David H. Li President and Chief Executive Officer - receipt
David Lee CEO - receipt
Luis Fernandez Moreno CEO - receipt
Mary Dean Hall Executive Vice President and Chief Financial Officer - receipt
Richard B. Kelson Chairman of the Board - receipt
Ruth Castillo Senior Vice President - receipt
Ryan Cotterman Vice President - receipt
familynone on file
upcoming
2026-11-04 earnings call scheduled ir
changes
2026-06-24 Vice President, appointed sec_8k
2025-10-23 Senior Vice President, appointed sec_8k
2025-03-10 President and Chief Executive Officer, appointed sec_8k
2021-03-24 Executive Vice President and Chief Financial Officer, appointed sec_8k
2020-02-20 Chairman of the Board, appointed sec_8k
mcp_package_hint
steadybase-$